Biofourmis Adds Jaydev Thakkar, Milan Shah to C-Suite

Digital therapeutics company Biofourmis has appointed Jaydev Thakkar as its chief operating officer, and Milan Shah as its chief technology officer. Thakkar joins Boston-based Biofourmis after 14 years at Amgen (NASDAQ: [[ticker:AMGN]]), where he was most recently director of digital health and innovation. Shah joins from cybersecurity firm Uptycs, where he was co-founder and chief technology officer. Biofourmis is developing software-based therapies and other technologies for various parts of the healthcare system.

Author: Frank Vinluan

Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times. View all posts by Frank Vinluan